Intestinal epithelial TOLLerance versus inTOLLerance of commensals.
暂无分享,去创建一个
[1] J. Cavaillon,et al. Gamma Interferon and Granulocyte/Monocyte Colony-stimulating Factor Prevent Endotoxin Tolerance in Human Monocytes by Promoting Interleukin-1 Receptor-associated Kinase Expression and Its Association to MyD88 and Not by Modulating TLR4 Expression* , 2002, The Journal of Biological Chemistry.
[2] Tomohiro Watanabe,et al. NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.
[3] M. Lazar,et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. , 1999, The Journal of clinical investigation.
[4] B. Franke,et al. NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease , 2004, European journal of immunology.
[5] G. Gerken,et al. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. , 2002, The American journal of pathology.
[6] Matthew T Wheeler,et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.
[7] D. Merlin,et al. TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism , 2003 .
[8] A. Young,et al. Prokaryotic Regulation of Epithelial Responses by Inhibition of IκB-α Ubiquitination , 2000 .
[9] J. Olivo-Marin,et al. Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. , 2003, Immunity.
[10] T. Crabtree,et al. Preexposure of murine macrophages to CpG-containing oligonucleotides results in nuclear factor kappaB p50 homodimer-associated hyporesponsiveness. , 2002, Surgery.
[11] M. Abreu,et al. TLR4 and MD-2 Expression Is Regulated by Immune-mediated Signals in Human Intestinal Epithelial Cells* , 2002, The Journal of Biological Chemistry.
[12] E. Cario. Toll-like receptors and gastrointestinal diseases: from bench to bedside? , 2002, Current opinion in gastroenterology.
[13] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[14] J. Richardson,et al. Identification of Acyloxyacyl Hydrolase, a Lipopolysaccharide- Detoxifying Enzyme, in the Murine Urinary Tract , 2004, Infection and Immunity.
[15] D. McKay,et al. Bacterial DNA evokes epithelial IL‐8 production by a MAPK‐dependent, NFκB‐independent pathway , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] J. Udagawa,et al. Strategic Compartmentalization of Toll-Like Receptor 4 in the Mouse Gut1 , 2003, The Journal of Immunology.
[17] P. Godowski,et al. Cutting Edge: Bacterial Flagellin Activates Basolaterally Expressed TLR5 to Induce Epithelial Proinflammatory Gene Expression1 , 2001, The Journal of Immunology.
[18] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[19] C. Datz,et al. Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. , 1999, The Journal of endocrinology.
[20] Jae-Geun Yoon,et al. CpG DNA Induces Self and Cross-Hyporesponsiveness of RAW264.7 Cells in Response to CpG DNA and Lipopolysaccharide: Alterations in IL-1 Receptor-Associated Kinase Expression1 , 2003, The Journal of Immunology.
[21] Rajnish A. Gupta,et al. Activation of Peroxisome Proliferator-activated Receptor γ Suppresses Nuclear Factor κB-mediated Apoptosis Induced by Helicobacter pylori in Gastric Epithelial Cells* , 2001, The Journal of Biological Chemistry.
[22] D. Podolsky,et al. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. , 2004, Gastroenterology.
[23] S. Akira,et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. , 2004, Gastroenterology.
[24] D. Podolsky,et al. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[25] D. Podolsky,et al. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[26] P. Felsburg,et al. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[27] R. Ulevitch,et al. Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors , 2004, Nature Immunology.
[28] S. Ohta,et al. Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling. , 2004, Biochemical and biophysical research communications.
[29] J. Auwerx,et al. Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer , 2001, The Journal of experimental medicine.
[30] H. Redmond,et al. Induction of Bacterial Lipoprotein Tolerance Is Associated with Suppression of Toll-like Receptor 2 Expression* , 2002, The Journal of Biological Chemistry.
[31] D. Podolsky,et al. Gamma Interferon Augments the Intracellular Pathway for Lipopolysaccharide (LPS) Recognition in Human Intestinal Epithelial Cells through Coordinated Up-Regulation of LPS Uptake and Expression of the Intracellular Toll-Like Receptor 4-MD-2 Complex , 2003, Infection and Immunity.
[32] F. Liew,et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance , 2004, Nature Immunology.
[33] M. Hornef,et al. Toll-like Receptor 4 Resides in the Golgi Apparatus and Colocalizes with Internalized Lipopolysaccharide in Intestinal Epithelial Cells , 2002, The Journal of experimental medicine.
[34] Takuji Tanaka,et al. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats. , 2001, Cancer research.
[35] B. Brüne,et al. Delayed activation of PPARγ by LPS and IFN-γ attenuates the oxidative burst in macrophages , 2001 .
[36] K. Dobashi,et al. Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4. , 2002, Immunology letters.
[37] D. Podolsky,et al. Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease , 2000, Infection and Immunity.
[38] G. Gilkeson,et al. PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR‐GAMMA AGONISTS MODULATE MACROPHAGE ACTIVATION BY GRAM‐NEGATIVE AND GRAM‐POSITIVE BACTERIAL STIMULI , 2003, Shock.
[39] Sankar Ghosh,et al. Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip* , 2002, The Journal of Biological Chemistry.
[40] C. De Simone,et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. , 2001, Gastroenterology.
[41] S. Pettersson,et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.
[42] G. Gerken,et al. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. , 2004, Gastroenterology.
[43] Johan Auwerx,et al. Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis , 2003 .
[44] A. Macpherson,et al. Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria , 2004, Science.
[45] D. Podolsky,et al. Lipopolysaccharide Activates Distinct Signaling Pathways in Intestinal Epithelial Cell Lines Expressing Toll-Like Receptors1 , 2000, The Journal of Immunology.
[46] D. Haller,et al. IKKβ and Phosphatidylinositol 3-Kinase/Akt Participate in Non-pathogenic Gram-negative Enteric Bacteria-induced RelA Phosphorylation and NF-κB Activation in Both Primary and Intestinal Epithelial Cell Lines* , 2002, The Journal of Biological Chemistry.
[47] F. Taddei,et al. In Vitro and ex Vivo Activation of the TLR5 Signaling Pathway in Intestinal Epithelial Cells by a Commensal Escherichia coli Strain* , 2004, Journal of Biological Chemistry.
[48] M. Abreu,et al. Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide1 , 2001, The Journal of Immunology.
[49] F. Martinon,et al. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor , 2000, Nature Cell Biology.
[50] Hong-Bing Shu,et al. A20 is a potent inhibitor of TLR3‐ and Sendai virus‐induced activation of NF‐κB and ISRE and IFN‐β promoter , 2004 .
[51] C. De Simone,et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. , 2004, Gastroenterology.
[52] M. Baldeón,et al. Evidence for an Innate Immune Response in the Immature Human Intestine: Toll-Like Receptors on Fetal Enterocytes , 2001, Pediatric Research.
[53] K. Michelsen,et al. Human Intestinal Epithelial Cells Are Broadly Unresponsive to Toll-Like Receptor 2-Dependent Bacterial Ligands: Implications for Host-Microbial Interactions in the Gut 1 , 2003, The Journal of Immunology.
[54] Y. Tao,et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. , 2004, Gastroenterology.
[55] S. Akira,et al. Cutting Edge: Endotoxin Tolerance in Mouse Peritoneal Macrophages Correlates with Down-Regulation of Surface Toll-Like Receptor 4 Expression1 , 2000, The Journal of Immunology.